Rheumatoid Arthritis Research and Therapies
This cluster of papers focuses on the pathogenesis, classification, management, and treatment outcomes of rheumatoid arthritis. It covers topics such as the role of inflammation, biological and disease-modifying therapies, autoantibodies, joint inflammation, cytokines, cardiovascular risk, synoviocytes, and the genetic contribution to the disease.
Papers listed on taxonomy pages are the top few works per node from the OpenAlex snapshot. That list is not exhaustive and is not an endorsement. The topic map and the journal registry remain separate: there is still no authoritative topic-to-venue or topic-to-organization edge. Search is a lexical lookup, not a claim that a venue publishes a topic.
Most cited
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- Revised Criteria for the Classification of Rheumatoid Arthritis
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
- The Pathogenesis of Rheumatoid Arthritis
Most recent
- Interference RNA and microRNA in Rheumatoid Arthritis: Diagnostic Biomarkers, Epigenetic Regulation, and Emerging Therapeutic Strategies
- Interference RNA and microRNA in Rheumatoid Arthritis: Diagnostic Biomarkers, Epigenetic Regulation, and Emerging Therapeutic Strategies
- ICHOM-aligned outcomes in patients with rheumatoid arthritis receiving biologic therapy: initial experience from a pilot observational study
- Association of socioeconomic status transition with arthritis: a life-course study
- Unsupervised machine learning with Cluster Analysis in patients with rheumatoid arthritis: insights in CV risk phenotypes from a multicentre Italian cohort
- Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational “real-life” GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study